Details

Autor(en) / Beteiligte

• Jenkins, David J.A.
• Spence, J. David
• Giovannucci, Edward L.
• Kim, Young-in
• Josse, Robert
• Vieth, Reinhold
• Blanco Mejia, Sonia
• Viguiliouk, Effie
• Nishi, Stephanie
• Sahye-Pudaruth, Sandhya
• Paquette, Melanie
• Patel, Darshna
• Mitchell, Sandy
• Kavanagh, Meaghan
• Tsirakis, Tom
• Bachiri, Lina
• Maran, Atherai
• Umatheva, Narmada
• McKay, Taylor
• Trinidad, Gelaine
• Bernstein, Daniel
• Chowdhury, Awad
• Correa-Betanzo, Julieta
• Del Principe, Gabriella
• Hajizadeh, Anisa
• Jayaraman, Rohit
• Jenkins, Amy
• Jenkins, Wendy
• Kalaichandran, Ruben
• Kirupaharan, Geithayini
• Manisekaran, Preveena
• Qutta, Tina
• Shahid, Ramsha
• Silver, Alexis
• Villegas, Cleo
• White, Jessica
• Kendall, Cyril W.C.
• Pichika, Sathish C.
• Sievenpiper, John L.

Titel

Supplemental Vitamins and Minerals for CVD Prevention and Treatment

Ist Teil von

• Journal of the American College of Cardiology, 2018-06, Vol.71 (22), p.2570-2584

Ort / Verlag

United States: Elsevier Inc

Erscheinungsjahr

2018

Quelle

Elsevier ScienceDirect Journals

Beschreibungen/Notizen

• The authors identified individual randomized controlled trials from previous meta-analyses and additional searches, and then performed meta-analyses on cardiovascular disease outcomes and all-cause mortality. The authors assessed publications from 2012, both before and including the U.S. Preventive Service Task Force review. Their systematic reviews and meta-analyses showed generally moderate- or low-quality evidence for preventive benefits (folic acid for total cardiovascular disease, folic acid and B-vitamins for stroke), no effect (multivitamins, vitamins C, D, β-carotene, calcium, and selenium), or increased risk (antioxidant mixtures and niacin [with a statin] for all-cause mortality). Conclusive evidence for the benefit of any supplement across all dietary backgrounds (including deficiency and sufficiency) was not demonstrated; therefore, any benefits seen must be balanced against possible risks. [Display omitted]